Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Bayer, AHA Collaborate to Advance Cardiovascular Research

By R&D Editors | November 15, 2016

 Bayer and the American Heart Association (AHA) today announced the launch of the 2017 AHA-Bayer Innovation and Discovery Grants Program. The program will support research initiatives within the AHA Institute for Precision Cardiovascular Medicine to advance scientific understanding and address unmet medical needs in cardiovascular disease. Specifically, Bayer will provide a total of $576,000 to fund three AHA-Bayer Discovery Target Grants, which AHA will award and administer in 2017.

“While we have made great progress in preventing and effectively treating cardiovascular diseases, there is still a great deal of research to be done,” said Nancy Brown, Chief Executive Officer at the AHA. “We are proud to collaborate with Bayer on this program and in our shared mission to advance innovation and transform foundational science to meet the needs of patients with limited treatment options.”

Cardiovascular and kidney diseases encompass a wide variety of conditions such as heart failure with preserved ejection fraction, acute kidney injury and atrial fibrillation. These and several other conditions with high unmet need will be included in the scope of research outlined in the grant partnership.

“Our collaboration with the AHA underscores Bayer’s history and long-standing commitment to advancing scientific research in cardiovascular and kidney disease management,” said Karl Ziegelbauer, PhD, Senior Vice President and Head of Therapeutic Research Groups in Drug Discovery at Bayer AG’s Pharmaceutical Division. “These grants will help support innovative research that can improve our understanding of these conditions and identify ways we can collaborate to find therapeutic solutions for these underserved diseases.”

A long-standing supporter and corporate sponsor of AHA, Bayer has a robust product portfolio and research pipeline in cardiovascular and kidney diseases including heart failure, diabetic kidney disease, and thrombosis. 

AHA will make the Request for Applications available in early 2017. Click here for more information or go to http://www.heart.org.

Related Articles Read More >

2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
Health-related innovation in Morocco highlighted by resident inventor patenting activity
ARPA-H funds $29M Ginkgo-led project to reshore pharma supply chains using wheat germ tech
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE